XXII | tickerfilter.com

Fundamental analysis

25%

Profitability 0%

Dept financing 27%

Liquidity 65%

Performance 40%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

-1.71%

1 Month

-45.19%

3 Months

-81.69%

6 Months

656.76%

1 Year

-53.02%

2 Year

-92.53%

Key data

Stock price

$0.79

P/E Ratio

0.00

DAY RANGE

$0.76 - $0.82

EPS

-$53.21

52 WEEK RANGE

$0.04 - $12.49

52 WEEK CHANGE

-$50.04

MARKET CAP

1.823 M

YIELD

N/A

SHARES OUTSTANDING

9.273 M

DIVIDEND

$0.00

EX-DIVIDEND DATE

12-17-2024

NEXT EARNINGS DATE

05-14-2025

BETA

2.60

PUBLIC FLOAT

AVERAGE 10 VOLUME

$172,335

AVERAGE 30 VOLUME

$1,632,709

Company detail

CEO: James A. Mish
Region: US
Website: xxiicentury.com
Employees: 80
IPO year: 2011

Issue type: Common Stock
Market: XNAS
Industry: Tobacco Products/Tobacco Products
Sector: Manufacturing

22nd Century Group, Inc. focuses on tobacco harm reduction, reduced nicotine tobacco, and enhancing health and wellness through plant science. The company has collaboration with Keygene N.V. to develop hemp/cannabis plants for exceptional cannabinoid profiles and other superior agronomic traits.

XXII - 22nd Century Group, Inc.